Putney Launches Generic Ketamine, Other Products In Pipeline



Published:

Putney Inc. of Portland, Maine, reported today that the U.S. Food and Drug Administration’s Center of Veterinary Medicine has approved its generic ketamine hydrochloride for injection.

Additional launches of generic pet medications are to follow, including analgesics, anti-infectives, anesthetics, sedatives, dermatologicals and parasiticides, according to Anthony Lucas, BVMS, Ph.D., senior director of product development.

Today’s launch follows the company’s carprofen caplet introduction in 2009. Since then, Putney has advanced its research and development pipeline of generic pet pharmaceutical products for submission to CVM.

These rollouts are just the beginning, Dr. Lucas said.

Putney’s ketamine hydrochloride, which comes in 10 mL vials (100 mg/mL), is indicated for use in cats for restraint or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation, according to the product’s label. It may also be used in subhuman primates for restraint.

Distributors currently carrying the product include D-V Medical Supply Inc., First Veterinary Supply, PCI Animal Health, Victor Medical Co. and Webster Veterinary.

<Home>

 

Archive »Read More

Summer Camp Helps Prepare High School Students for Vet Careers

The summer camp is now hosted annually by The Ohio State University College of Veterinary Medicine.

N.Y. Clinic Gets Facelift Courtesy of Novartis

Village Vet of Lewiston wins Novartis Animal Health’s Onsior Clinic Makeover contest.

Ceva Animal Health Gallops Into Equine Market

Altresyn, ConfidenceEQ and Tildren are among the first products offered through Ceva’s new equine division.

Add your comment: